Somatostatin analog
Somatostatin analog is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
3
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia
Clinical Trials (5)
Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Fatigue and Quality of Life in Patients With Neuroendocrine Neoplasia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5